Abiopharma

🔍 Hill Kathryn (Director)

Company: Celanese Corp (CE)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 1 shares of Phantom Stock (Derivative)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,142.54 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each share of phantom stock represents the right to receive one share of Common Stock.
• F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.